Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co selects Ireland for USD 280m biologics site

Merck & Co locates its site for a new vaccines and biologics facility in the Republic of Ireland with an investment of USD 280m

US-based Merck & Co has located its site for a new vaccines and biologics facility in the Republic of Ireland with an investment EUR 200m (USD 280m).

The plant is scheduled to begin operations by 2011 and will employ 170 people across production, engineering, R&D, quality control, management and administration.

Ireland's Industrial Development Agency (IDA) said that Merck & Co's decision was a very significant consolidation of Ireland's high profile position as a successful location for substantial biotechnology global investments.

The 65-acre IDA Business and Technology Park is located in Carlow and will be Ireland's first stand-alone human vaccine project. The new facility will perform formulation and sterile filling activities, as well as conducting R&D operations to support recently launched vaccines and future projects.

According to the IDA, Merck & Co, which operates as Merck, Sharp and Dohme in the country, will also recruit local academic talent to leverage opportunities in developing biologic products.

Merck & Co, who already has two other plants in Ireland, joins Abbott which operates seven sites, Johnson & Johnson with six, Pfizer with five and Schering Plough and GlaxoSmithKline (GSK) which both have four sites.

29th November 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics